1. Home
  2. ASTH vs NBTX Comparison

ASTH vs NBTX Comparison

Compare ASTH & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astrana Health Inc.

ASTH

Astrana Health Inc.

HOLD

Current Price

$24.79

Market Cap

996.1M

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$34.17

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTH
NBTX
Founded
1994
2003
Country
United States
France
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
996.1M
1.0B
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
ASTH
NBTX
Price
$24.79
$34.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$35.33
$26.00
AVG Volume (30 Days)
571.8K
34.4K
Earning Date
06-04-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.33
N/A
Revenue
$519,907,752.00
N/A
Revenue This Year
$26.88
N/A
Revenue Next Year
$10.78
$11.73
P/E Ratio
$75.91
N/A
Revenue Growth
45.90
N/A
52 Week Low
$18.08
$2.95
52 Week High
$34.80
$37.11

Technical Indicators

Market Signals
Indicator
ASTH
NBTX
Relative Strength Index (RSI) 58.63 69.64
Support Level $23.37 $20.11
Resistance Level $28.49 N/A
Average True Range (ATR) 1.35 2.03
MACD 0.82 0.84
Stochastic Oscillator 76.37 80.35

Price Performance

Historical Comparison
ASTH
NBTX

About ASTH Astrana Health Inc.

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: